Atrial Natriuretic Factor - Blood
Research News and Information

Sunday, November 22, 2009

Brain-type natriuretic peptide at birth reflects foetal maturation and antenatal stress.

30 Aug 2009 AIM: Antenatal stress, maturation and other foetal conditions affect the postnatal cardiovascular function. Atrial- (ANP) and brain-type natriuretic peptide (BNP) play important roles in regulating extracellular fluid volume and blood pressure, ... Read more...

Baroreflex sensitivity is impaired in patients with obstructive jaundice.

30 Aug 2009 BACKGROUND: Obstructive jaundice is associated with enhanced susceptibility to hypotensive shock, renal failure, and toxic effects of endotoxin, which results in high perioperative morbidity and mortality. Since the normal arterial baroreflex ... Read more...

Validity, prognostic value and optimal cutoff of respiratory muscle strength in patients with chronic heart failure changes with beta-blocker treatment.

30 Jul 2009 BACKGROUND: Training studies frequently use maximum inspiratory mouth occlusion pressure (PImax) as a therapeutic target and surrogate marker. For patients on beta-blocker (BBL), prognostic data allowing this extrapolation do not exist. Furthermore, ... Read more...

Latest indexed articles for 'Atrial Natriuretic Factor - Blood'

These are the very latest articles for this heading:

• Brain-type natriuretic peptide at birth reflects foetal maturation and antenatal stress. 30 Aug 2009
• Baroreflex sensitivity is impaired in patients with obstructive jaundice. 30 Aug 2009
• Validity, prognostic value and optimal cutoff of respiratory muscle strength in patients with chronic heart failure changes with beta-blocker treatment. 30 Jul 2009
• Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease. 25 Jul 2009
• [Chronic obstructive pulmonary disease and heart failure] 10 Jul 2009
• Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. 29 Jun 2009
• BNP/NT-proBNP and cardiac pacing: a review. 30 May 2009
• The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation. 30 May 2009
• Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community. 30 May 2009
• Serum levels of natriuretic peptides in children with various types of loading conditions. 30 May 2009
• Supraventricular tachycardia. Comment. 30 May 2009
• A familial mutation renders atrial natriuretic Peptide resistant to proteolytic degradation. 17 May 2009
• Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea. 16 May 2009
• Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death. 10 May 2009
• Whole-body basal nitric oxide production is impaired in postprandial endothelial dysfunction in healthy rats. May 2009
• Plasma atrial natriuretic peptide in healthy calves and calves with congenital heart disease. 29 Apr 2009
• Clinical significance of elevated natriuretic peptide levels and cardiopulmonary parameters after subarachnoid hemorrhage. 29 Apr 2009
• Antagonistic effects of atipamezole and yohimbine on xylazine-induced diuresis in healthy dogs. 29 Apr 2009
• Hyper osmolality does not modulate natriuretic peptide concentration in patients after coronary artery surgery. 29 Apr 2009
• Inflammatory mediators in Chinese patients with congestive heart failure. 29 Apr 2009

See a longer list of these articles.

Technical information about 'Atrial Natriuretic Factor'

Definition: A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS.

Chemical name: Atriopeptin

Registry Number: 85637-73-6

Descriptor UI: D009320

Alternative terms: Atrial Natriuretic Factor; Auriculin; ANP; Natriuretic Peptides, Atrial; ANF; Atriopeptins; Atrial Natriuretic Peptides; Peptides, Atrial Natriuretic; beta-Atrial Natriuretic Peptide; beta Atrial Natriuretic Peptide; beta-ANP; beta ANP; alpha-ANP Dimer; alpha ANP Dimer; alpha-Atrial Natriuretic Peptide; alpha Atrial Natriuretic Peptide; ANP-(99-126); Atriopeptin (99-126); Cardionatrin I; Atrial Natriuretic Factor (99-126); ANF (1-28); Atriopeptin (1-28); Atrial Natriuretic Factor (1-28); gamma ANP (99-126); alpha ANP; Cardiodilatin (99-126); ANP Prohormone (99-126); ANF (99-126); ANP (1-28); Atrial Natriuretic Factor Precursors; Prepro-Cardiodilatin-Atrial Natriuretic Factor; Prepro Cardiodilatin Atrial Natriuretic Factor; Prepro-ANP; Prepro ANP; ANF Precursors; Cardiodilatin Precursor; Prepro-CDD-ANF; Prepro CDD ANF; gamma-Atrial Natriuretic Peptide; gamma Atrial Natriuretic Peptide; Atriopeptin Prohormone (1-126); Proatrial Natriuretic Factor; Pronatriodilatin; Atriopeptin 126; Cardionatrin IV; Atrial Natriuretic Factor Prohormone; Atrial Natriuretic Factor (1-126); Atrial Natriuretic Peptide (1-126); Atriopeptigen; ANF (1-126); ANP (1-126); Atrial Pronatriodilatin; Pro-ANF; Pro ANF; ProANF;

Related Mesh Headings: Receptors, Atrial Natriuretic Factor;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D06.472.699.584.500; D12.644.548.585.500;

History Note: 1992, use NATRIURETIC PEPTIDES, ATRIAL 1986-1991; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIAL NATRIURETIC FACTOR (99-126) 1987-2003; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIAL NATRIURETIC FACTOR (1-28) 1992-2003; use ATRIAL NATRIURETIC FACTOR (NM) for CARDIONATRIN IV 1986-2003; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIOPEPTIGEN 1985-2003; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIAL NATRIURETIC FACTOR PRECURSORS 1985-2003